EMPIRE: The Effect of Music on Patients in Critical Care

Sponsor
Chelsea and Westminster NHS Foundation Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT04847570
Collaborator
CW plus (Other), Imperial College London (Other)
30
1
1
5.7
5.2

Study Details

Study Description

Brief Summary

The EMPIRE study will assess the effect of music listening on patients in critical care. 30 patients from the Adult Intensive Care Unit (AICU) at Chelsea and Westminster Hospital will be recruited to undergo a single 40-minute session of supervised music listening. Before and after the session, patients will be asked to describe their pain and anxiety on a rating of 1-10, and the patient's level of agitation/sedation will also be measured. In addition, physiological data such as heart rate, respiratory rate, blood pressure and level of sedation (bispectral index score) will be measured throughout the listening session. Finally, a 3-month follow-up interview will be conducted to assess the influence of the music on participants' experience of the Adult Intensive Care Unit.

Condition or Disease Intervention/Treatment Phase
  • Other: Music session
N/A

Detailed Description

The EMPIRE study will assess the effect of music listening on patients in critical care. Treatment on an intensive care unit can be disorientating and frightening, with patients at risk of delirium and post-traumatic stress disorder. The COVID-19 pandemic has exacerbated some of the factors which might contribute to this, such as lack of visits from relatives and friends, increased difficulty communicating with staff, and an increased likelihood of being on mechanical ventilation and sedation. Music has shown the potential to be a low-cost non-pharmacological intervention which can improve patients' experience of acute care without adding significantly to the workload of staff.

Studies have suggested that music listening has the potential to reduce feelings of pain and anxiety in critical care patients, as well as improved autonomic physiological outcomes such as heart rate, respiratory rate and blood pressure.

The EMPIRE study will seek to explore the effects described above in greater detail. 30 patients from the Adult Intensive Care Unit (AICU) at Chelsea and Westminster Hospital will be recruited to undergo a single 40-minute session of supervised music listening, in which they will be encouraged to request their favourite music if they are able. Before and after the session, patients will be asked to describe their pain and anxiety on a rating of 1-10, and the patient's level of agitation/sedation will also be measured, so that changes in these can be evaluated. In addition, physiological data such as heart rate, respiratory rate, blood pressure and level of sedation (bispectral index score) will be measured throughout the listening session, and later analysed for significant changes in relation to the music that was being played. Finally, a 3-month follow-up interview will be conducted to assess the influence of the music on participants' experience of the Adult Intensive Care Unit.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Non-clinical interventionNon-clinical intervention
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Effect of Music on Patients in Critical Care (EMPIRE)
Actual Study Start Date :
Apr 13, 2021
Anticipated Primary Completion Date :
Oct 4, 2021
Anticipated Study Completion Date :
Oct 4, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Music listening experience

It is a single-arm non-randomised study. The same inclusion and exclusion criteria applies to all the participants.

Other: Music session
Non-clinical intervention only, and no change to clinical care or treatment. Participants will have 10 minutes of undisturbed rest, followed by a supervised music-listening session of up to 40 minutes, ending with another 10-minute rest period.

Outcome Measures

Primary Outcome Measures

  1. Investigate the effect of music on state anxiety [6 months]

    Verbal anxiety rating, 0-10, pre/post.

  2. Investigate the effect of music on pain [6 months]

    Either ONRS 0-10, or C-POT 0-8, pre/post

  3. Investigate the effect of music on agitation [6 months]

    RASS, -5 to +4, pre-/post

  4. Investigate the effect of music on HR [6 months]

    Measured in beats per minute

  5. Investigate the effect of music on RR [6 months]

    Measured in breaths per minute

  6. Investigate the effect of music on DBP and SBP [6 months]

    Measured in mm Hg

  7. Investigate the effect of music on BIS [6 months]

    Measured using the Bispectral index (BIS)

  8. Investigate the longitudinal effects of music on ICU experience [3 months]

    Follow up interview 3 months later

Secondary Outcome Measures

  1. Correlation analysis of continuous HR, RR, BP and BIS data with the following musical analysis data (drawn from the Spotify API): [6 months]

    Acousticness (0-1) Danceability (0-1) Duration (continuous) Energy (0-1) Instrumentalness (0-1) Key (0-11) Liveness (0-1) Loudness (db, c.-60 to 0) Mode (0-1) Speechiness (0-1) Tempo (continuous) Time Signature (continuous) Valence (0-1)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Nominated for participation by the clinical team of the Chelsea and Westminster Hospital AICU

  • Level 1-3 critical care inpatient at Chelsea and Westminster Hospital AICU

  • Age 18 or above

  • English speaking

  • RASS score >-2

  • No significant hearing loss (able to hear music being played)

  • Consent obtained from patient or advice sought from consultee (personal or nominated (professional))

Exclusion Criteria:
  • Under 18 years of age

  • Non-English speaking

  • RASS score <-2

  • Significant hearing loss (not able to hear music being played)

  • Unable to obtain consent from patient or receive advice from consultee (personal or nominated)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chelsea and Westminster Hospital NHS Foundation Trust London United Kingdom SW10 9NH

Sponsors and Collaborators

  • Chelsea and Westminster NHS Foundation Trust
  • CW plus
  • Imperial College London

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Chelsea and Westminster NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04847570
Other Study ID Numbers:
  • C&W21/009
First Posted:
Apr 19, 2021
Last Update Posted:
Aug 6, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chelsea and Westminster NHS Foundation Trust

Study Results

No Results Posted as of Aug 6, 2021